期刊名称:NATURE IMMUNOLOGY

ISSN:1529-2908
版本:SCI-CDE
出版频率:Monthly
出版社:NATURE PORTFOLIO, HEIDELBERGER PLATZ 3, BERLIN, Germany, 14197
  出版社网址:http://www.nature.com/
期刊网址:http://www.nature.com/ni/index.html
影响因子:25.606
主题范畴:IMMUNOLOGY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

 

Aims and Scope: Nature Immunology brings together the most significant immunology from every discipline within a single high-profile journal. Internationally peer-reviewed, Nature Immunology presents only the most influential, important or conceptually novel work. Expert News and Views, Commentaries, Reviews and discussion of work published in Nature Immunology and other relevant journals complement its research content.

Nature Immunology's scope is broad. Presenting the research that provides fundamental insight into the working of the immune system, Nature Immunology communicates the most significant advances and ideas to a wide audience.

 


Instructions to Authors

 

Manuscript Selection Criteria

 

Nature Immunology is a multidisciplinary journal that aims to publish papers of the highest quality and significance in all areas of immunology. Although no area is excluded from consideration, priority is given to those studies that provide fundamental insights into the functioning of the immune system.

Nature Immunology is read by immunologists from diverse backgrounds and many are not native English speakers. Authors should therefore give careful thought to how their findings may be communicated clearly. Although a shared basic knowledge of immunology and general biology may be assumed, please bear in mind that the language and concepts that are standard in one discipline may be unfamiliar to non-specialists. Thus, technical jargon should be avoided as far as possible and clearly explained where its use is unavoidable. Abbreviations, particularly those that are not standard, should also be kept to a minimum. The background, rationale and main conclusions of the study should be clearly explained. Titles and abstracts in particular should be written in language that will be readily intelligible to any immunologist. We strongly recommend that authors ask a colleague from another field to review the manuscript before submission, in order to identify concepts and terminology that may present difficulties to non-specialist readers.

Like the other Nature titles, Nature Immunology does not have an external editorial board. Instead, manuscripts are considered by the full-time editorial staff, who select those that are to be formally reviewed. Such decisions are often based on informal expert advice, but they are ultimately editorial judgments as to whether the manuscript is likely to be of sufficient general interest for the journal's broad multidisciplinary readership. Those considered unsuitable are returned promptly; those judged to be of greatest potential interest are sent for review by independent experts. The editors then make a decision based on the referees' advice and other editorial considerations.

Nature Immunology places a high priority on rapid review and publication. Decisions on whether to send a manuscript out for peer review are normally made within about a week of receipt. Editorial decisions about publication are typically made within a day or two after we receive the referees' reports. Manuscript receipt is confirmed by e-mail; editorial decisions are normally communicated to the authors by fax or e-mail.

Manuscripts from Other NPG Journals

 

When authors elect to submit work to Nature Immunology after review at Nature (or another Nature group title), Nature will release its referees' comments to us, upon consent of the authors. In cases where the work was felt to be of high quality, papers can sometimes be accepted without further review, but if there are serious criticisms, we will consider these in making our editorial decision. It is helpful to the editors if the authors include with any resubmission a letter explaining the relationship between the submitted manuscript and the previous Nature submission and (assuming it has been revised in light of the referees' criticisms) giving a point-by-point response to the referees. Based on the referees' reports and the authors' response, the editors will then decide whether to seek further advice from referees.

Conditions of Publication

 

Press Coverage
Publication in Nature Immunology is conditional on there being no prior disclosure of the work to the media. Thus, authors should not give press conferences or otherwise encourage or cooperate with media coverage of submitted work, except on the understanding that the embargo will be respected. Failure to do so may prejudice further consideration of the manuscript. This policy is in no way intended to restrict legitimate scientific discussion, thus the presentation of results at scientific meetings (including the publication of brief abstracts) is acceptable, as is the deposition of data in electronic archives.

Once scheduled for publication, some contributions are selected by the editors for inclusion in the weekly press release. This provides a brief summary, together with contact details for the authors, and is distributed to the media a week before the publication date. Authors of accepted contributions scheduled for publication may also arrange their own publicity (for instance through their institutional press offices), but they must strictly adhere to our press embargo.

Advance Online Publication
Note that Nature Immunology now supports Advance Online Publication (AOP) of research articles, which benefits authors with an earlier publication date and allows our readers access to accepted papers weeks before they are printed. Details of this policy can be viewed by linking to the Nature Immunology editorial on AOP published in our November, 2001 issue. Authors will be provided an estimated AOP publication date when the galley proofs are sent for preview.

Note that papers published online are definitive and may be altered only through the publication of a print corrigendum or erratum.

Competing Financial Interests
In the interests of transparency, the Nature Publishing Group (NPG) journals now require authors of original research, Review and Perspective articles to declare any competing financial interests in relation to papers accepted for publication. For details, please see our policy and the Nature Immunology editorial published in the October 2001 issue.

Materials
As a condition of publication, authors are required to make materials and methods used freely available to academic researchers for their own use. Authors are required to state in the methods section any conditions for use of materials, and to provide full disclosure of the conditions on a freely accessible, identified web site.

This requirement includes antibodies and the constructs used to make transgenic animals, but not the animals themselves. Mutant strains of mice generated without the use of constructs must be submitted to a public repository at the time of publication, unless authors can ensure prompt distribution to academic researchers on request.

Papers reporting protein or DNA sequences and crystallographic structures will not be accepted without an accession number to GenBank/EMBL/DDBJ, Brookhaven, SWISS-PROT or other appropriate, identified, publicly available database in general use in the field that gives free access to researchers from the date of publication (see Nature 394, 105; 1998 and 404, 317; 2000). Accession numbers are provided directly to authors by these databases on deposition of data, and must be included in the Nature paper before publication. Microarray data should be made freely available to academic researchers on authors' own web sites or other freely available web site (the URL to be provided in the paper) until a public database is available.

Microarrays
Please see the MGED open letter specifying microarray standards at http://www.mged.org/Workgroups/MIAME/miame_checklist.html, and see Nature Immunology 4, 93; 2003 and Nature 419, 323; 2002 for explanation of the policies of the journal and the Nature family of journals. In brief, authors submitting manuscripts containing microarray data must supply the data on a CD at the time of submission. The data must be MIAME-compliant and supplied in a form that is widely accessible, with the completed MIAME checklist also placed on the CD. Five copies of the CD are required, so that they can be sent to referees. Nature Immunology also requires submission of microarray data to the GEO (http://www.ncbi.nlm.nih.gov/geo/) or ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) databases, with accession numbers provided at or before acceptance for publication. Data may be posted on the Nature Immunology website as Supplementary Information only by prior agreement, as generally we are unable to host very large Supplementary Information files.

Other supporting data sets must be made available to any interested reader on the publication date from the authors directly.

Researchers who encounter a persistent refusal by an author of a Nature paper to comply with these guidelines should contact the Editor of Nature Immunology, at immunology@natureny.com. (See Nature 416, 1; 2002 .)

Animal Welfare and Informed Human Consent
In cases where a study involves the use of live animals or human subjects, the Methods section of the manuscript should include a statement that all experiments were performed in compliance with the relevant laws and institutional guidelines, and should identify the institutional committee(s) that have approved the experiments. A statement should also be included that informed consent was obtained for any experimentation with human subjects. Referees may be asked to comment specifically on any cases in which concerns arise.

Nomenclature
Authors should make sure that they use appropriate nomenclature for gene symbols. Please consult the appropriate nomenclature committee for correct gene name and symbol. Approved human gene symbols are provided by HUGO Gene Nomenclature Committee (HGNC), e-mail: nome@galton.ucl.ac.uk; http://www.gene.ucl.ac.uk/nomenclature/. Approved mouse nomenclature are provided by The Jackson Laboratory, e-mail: nomen@informatics.jax.org; http://www.informatics.jax.org/mgihome/nomen/.
 

Presubmission Inquiries

 
We are happy to answer presubmission inquiries, but it is often difficult to assess a manuscript from a short abstract alone, so in most cases we shall be unable to promise that a manuscript will be reviewed until we have seen it in its entirety. Thus, responses to presubmission inquiries should be construed as guidance for authors rather than definitive editorial judgments. Inquiries can be sent to us through our electronic submission system (
www.nature.com/ni/esubmission) or addressed to the Editor and sent by e-mail to immunology@natureny.com. If you use the web submission system, please make sure that you indicate that it is a presubmission inquiry and provide your e-mail, phone and fax numbers. To facilitate a rapid response, please send an abstract describing the experimental methods and results, along with a brief cover note explaining the central advance, its broad interest and significance, and citing any key references (including references to unpublished work under consideration elsewhere).
 

How to Submit

 
Nature Immunology prefers that all manuscripts be submitted through our electronic web submission system (
www.nature.com/ni/esubmission). If you have ever been an author on a submission to Nature Immunology, or if you have either been asked to review, or have reviewed a manuscript for the journal, it is likely we already have you registered in our system and you needn't register again. In this instance, you can gain access to your personal Nature Immunology homepage by clicking on the "Unknown/Forgotten Password" link on the web submission login homepage (http://mts-ni.nature.com). Completely new users can register first, and then access the form for submission. Detailed instructions are available at www.nature.com/ni/esubmission. If you use the web submission system, please do not send any hard copies of your manuscript unless requested by the editors. We require electronic versions of manuscripts and figures once a manuscript has been accepted; authors of accepted papers will receive further instructions on electronic formats at that time.

Online submission of manuscripts is strongly encouraged and allows prompt consideration of papers. Authors who have not submitted electronically are contacted and asked to do so before the paper is seen by the editors. This delays manuscripts. However, if circumstances make it impossible for you to use the online submission system, please submit two hard copies along with disks containing the text and figures.

Your submission letter should include a brief synopsis of the major findings in the paper that will be of general interest to most immunologists. Authors are welcome to suggest possible referees; these suggestions are often helpful, although they are not necessarily followed. Authors may also request the exclusion of individuals with a potential conflict of interest; if the number of exclusions is more than four, we cannot guarantee that we will honor these requests.

Submission to Nature Immunology is taken to imply that the work is novel, and unpublished and that there is no significant overlap between the submitted manuscript and any other papers under consideration or in press elsewhere. Authors may include supplementary information for the referees' inspection. Please provide four copies, clearly labeled. The manuscript should be accompanied by a cover letter from the corresponding author, who should be clearly identified on the manuscript, along with corresponding address, phone, fax and e-mail.
 

Authorship and Copyright

 
Submission is taken to imply that all coauthors have approved the contents of the manuscript and its submission by the corresponding author. (The corresponding author for editorial purposes need not be the senior author, or the person to whom correspondence is addressed after publication.) Statements of equal contribution from more than one author are permitted. The cover sheet of the manuscript should indicate the date of submission (or revision/resubmission). If the manuscript includes personal communications, please provide a written statement of permission from any person who is quoted. Printouts of e-mail permission messages are acceptable.

The Nature Publishing Group does not require authors to transfer their copyright. Instead, we ask for an exclusive licence. In return, authors will be free to reuse their papers in any of their future printed work, and have the right to post a copy of the published paper on their own websites.

In addition, authors - and the institutions in which they work - will be free to use their papers in course packs.

For form and detailed explanation, click here. (US government employees, click here.)


 
Types of Contributions

 

Primary Research Formats

An Article is a substantial novel research study, with a complex story often involving several techniques or approaches. The main text (excluding abstract, Methods, references and figure legends) is 3000?4000 words. The abstract is typically 110 words, unreferenced. Articles have 6?8 display items (figures and/or tables). An introduction (without heading) is followed by sections headed Results, Discussion and Methods. The Results and Methods should be divided by topical subheadings; References are limited to 50.

Articles include a competing financial interests statement and received/accepted dates. They may be accompanied by supplementary information. Articles are peer reviewed.

Other Formats

Correspondence is a flexible format that may include anything of interest to the journal?s readers, from policy debates to announcements to ?matters arising? from research papers. A Correspondence may describe primary research data, but only in summary form; this format is not intended for full presentation of data. Correspondence should never be more than one printed page, and usually much less. References from a Correspondence and its Reply are combined into a single list, numbered in order of appearance and placed at the end of the Reply. The number of references should not exceed 10 for either the Correspondence or its Reply. Titles are supplied by the editors.

Correspondence is the only section of the journal that may include replies from people whose views or findings are being criticized. Authors whose primary research data are being criticized should normally have the right of public reply. Criticism of opinions or other secondary matter do not involve an automatic right of reply.

Except for refutations, Correspondence is not normally peer reviewed (although it may be at the editors? discretion).

A Review is an authoritative, balanced and scholarly survey of recent developments in a research field. The requirement for balance need not prevent authors from proposing a specific viewpoint, but if there are controversies in the field, the authors must treat them in an even-handed way. Reviews are normally 3,000?4,000 words, and illustrations are strongly encouraged. References are limited to 100, with exceptions possible in special cases. Citations should be selective. The scope of a Review should be broad enough that it is not dominated by the work of a single laboratory, and particularly not by the authors? own work.

Reviews include a competing financial interests statement but not received/accepted dates. Reviews are always peer reviewed to ensure factual accuracy, appropriate citations and scholarly balance.

Commentary is a very flexible format; Commentaries may be on policy, science and society or purely scientific issues. The main criteria are that they should be of immediate interest to a broad readership and should be written in an accessible, non-technical style. In contrast to a Review, publication as a Commentary does not imply editorial endorsement of the authors? opinions. Their length is typically 1?4 pages, although some may be longer. Because the content is variable, the format is also flexible. Commentaries do not contain primary research data, although they may present ?sociological? data (funding trends, demographics, bibliographic data, etc.). References are limited to 25, and article titles are omitted from the reference list.

The related format Historical Commentary is a journalistic treatment of the history of a particular discovery or technical development. These pieces may be a personal account by one of the participants or may present strong personal opinions. This format does not necessarily seek scholarly balance, and it should be journalistic and accessible rather than scholarly in style.

A competing financial interests statement is optional, at the authors? discretion, although authors are encouraged to indicate their affiliations. Commentaries may be peer reviewed at the editors? discretion.

Perspective is a new format for scholarly reviews and discussions of the primary research literature that are too technical for a Commentary but do not meet the criteria for a Review?either because the scope is too narrow, or because the author is advocating a controversial position or a speculative hypothesis or discussing his/her own work. Two reviews advocating opposite sides in a research controversy are normally published as Perspectives. The text should not normally exceed 3000 words. References are limited to 50.

The related format Historical Perspective is a more technical account of a particular scientific development. Like other Perspectives, and in contrast to Historical Commentary, Historical Perspectives are scholarly reviews, including citation of key references, aiming to present a balanced account of the historical events, not merely personal opinions or reminiscences.

Perspectives include a competing financial interests statement but not received/accepted dates. Perspectives are always peer reviewed.

News and Views are by prior arrangement only. Although unsolicited contributions are rarely published, prospective authors are welcome to make proposals.

Book Reviews are by prior arrangement only, although suggestions are welcome.
 

Format

 
The editors provide detailed advice about format before contributions are formally accepted for publication. A high priority of Nature Immunology is that all papers be accessible to nonspecialists. Manuscripts are subject to substantial editing to achieve this goal. After acceptance, a copy editor may make further changes so that the text and figures are readable and clear to those outside the field and so that papers conform to our style (including American English spelling).

Contributors are sent proofs and are welcome to discuss proposed changes with the editors, but Nature Immunology reserves the right to make the final decision about matters of style and the size of figures.

References

The reference format for Nature Immunology is identical to that of Nature. References are numbered sequentially as they appear in the text, tables and figure legends. The maximum number of references is 50 for Articles. Only one publication is given for each number, and footnotes are not used. Only papers that have been published or accepted by a named publication should be in the numbered list; papers in preparation should be mentioned in the text with a list of authors (or initials if any of the authors are coauthors of the present contribution). Published conference abstracts and URLs for web sites should be cited parenthetically in the text, not in the reference list. Grant details and acknowledgments are not permitted as numbered references. All authors should be included in reference lists unless there are more than five, in which case only the first author should be given, followed by 'et al.'. Authors should be listed surname first, followed by a comma and initials of given names. Titles of all cited articles are required for all contributions. Titles should be reproduced exactly as they appear in the work cited, ending with a period. Journal names are italicized and abbreviated according to common usage; refer to Index Medicus for details. Volume numbers appear in bold. For book citations, the publisher and city of publication are required.

Acknowledgments

Acknowledgments follow the reference list. They should be brief, and should not include thanks to anonymous referees and editors, or effusive comments. Grant or contribution numbers may be acknowledged.

Figures

Figure legends for Articles begin with a brief title for the whole figure and continue with a short description of each panel and the symbols used. In general, visual cues are preferred to verbal explanations in the legend (e.g. "broken line", "open red triangles" etc.). Ideally legends consist of only one paragraph; move excess detail to the Methods. A statement should be included as to the reproducibility of the data shown. P-values should be stated for all data reported to be significant.

Figures should be presented on separate sheets of paper attached to each copy of the manuscript. Please include one original figure (preferably glossies) and three copies of sufficient quality for review. The figures should be attached to the review copies of the manuscript (rather than enclosed in a separate envelope). In general, multi-part figures should be arranged as they would appear in the final version. Please avoid sending oversized figures (larger than 8.5 x 11" or A4) wherever possible. Each copy should be marked with the figure number and the corresponding author's name. Reduction to the scale that will be used on the page is not necessary, but any special requirements (such as the separation distance of stereo pairs) should be clearly specified. Unnecessary figures and parts (panels) of figures should be avoided: data presented in small tables or histograms, for instance, can generally be stated briefly in the text instead. Figures should not contain more than one panel unless the parts are logically connected; each panel of a multipart figure should be sized so that the whole figure can be reduced by the same amount and reproduced on the printed page at the smallest size at which essential details are visible.

Electronic versions of figures will be requested when a manuscript is accepted for publication and details of acceptable electronic formats will be provided at that time (see below). Please do not send disk copies with the initial manuscript submission, as this merely creates confusion in the event that figures are subsequently modified.

Lettering on figures should be in a clear, sans-serif typeface (Helvetica or equivalent); if possible, the same typeface should be used for all figures in a paper. Figures should be on a white background, and should avoid excessive boxing, unnecessary color, spurious decorative effects (such as three-dimensional 'skyscraper' histograms) and highly pixilated computer drawings. The vertical axis of histograms should not be truncated to exaggerate small differences. The line spacing should be wide enough to remain clear on reduction to the minimum acceptable printed size.

Authors will see a proof of figures. Reasonable requests to enlarge figures will be considered, but editors will make the final decision on figure size. For files supplied so large that they will need to be substantially reduced, labels must be of a sufficient size and contrast to withstand appropriate reduction. In micrographs, scale bars should be used rather than magnification factors, with the length of the bar defined in the legend rather than on the bar itself. If the magnification is given in the legend instead, and we have to reduce your figure, a note will be added in proof for you to check the recalculation of scale is correct. Please ensure you do this.

Cover Art

Authors are encouraged to submit possible cover art for consideration. Cover images are normally linked to specific papers in that issue, but we may also be able to use other images elsewhere in the journal. Illustrations are selected for their scientific interest and esthetic appeal. Please send prints (rather than slides or electronic files) in the first instance. Please also include a clear and concise explanation.

Checklist for Original Artwork

  • For line artwork, high quality black and white printouts should be sent- do not send photocopies.
  • Hard copies of grayscale figures must be first generation glossy prints. Please do not send printouts of grayscales figures, as the dot pattern on a laser print often creates a moirîaattern when scanned.
  • Note: we cannot be held responsible for assuming the cost of corrected reprints should poor quality images need to be used.

Style Points to Bear in Mind when Creating Figures

  • Ideally do not place figure numbers (1a,b etc.) on digital files ? leave them clean. Instead, the file names should identify the figure and panel; hard copies should be labeled on the reverse side.
  • When adding labels within a figure, use an initial capital letter then lower case letters, units should follow, in parentheses, e.g. "Total protein (mg)". Please use a sans-serif font such as Helvetica, and use the Symbol font for Greek characters.
  • Units should have a single space between the number and the unit, and follow SI nomenclature or the nomenclature common to a particular field.
  • Unusual units or abbreviations should be spelled out in full or defined in the legend.
  • Italicize any genes, use a regular type for proteins.
  • Thousands should be separated by commas (1,000) and rarely used (instead, include "103" in front of the units in the axis label).

Avoid

  • Boxing around graphs and figures.
  • Highly pixilated computer drawing.
  • Unnecessary use of italics and bold on the figure.
  • Using massively oversized lettering or adding headings to actual graphs - include them in the figure legend instead.
  • Overly demarcated axes that cannot be reduced legibly.

Multipart Figures

  • If you have already labeled the figure and it is divided into several parts, the parts should be labeled a, b, c and so on.
  • If a part is further subdivided, the subparts should be labeled A, B, C.
  • On grayscales avoid unnecessary use of a, b and so on where it is simple to refer to left or right, upper or lower parts.
  • Lanes on gels, spectral traces, and so on, should be numbered rather than labeled with letters.

Symbols in Figures

  • A figure should convey information 'at a glance' without the reader having to pick through a convoluted legend. So we prefer, for example, "()" to "filled circle" in legends.
  • It is acceptable to provide labels for the curves on a graph or a key to define symbols but two factors should be taken into consideration: if the curves merit lengthy explanation or the symbols denote complex experimental groupings, this will be best written out in the legend to avoid clutter; if figures need to be substantially reduced, keys or labels within the graph that are in small type will become illegible and will therefore be removed.
  • Common symbols that are used include filled (not 'closed') and open circles, triangles, squares and diamonds
  • Crosses should be avoided because they do not reproduce well.

Credits

  • Figures that have been reproduced from elsewhere must be acknowledged: "(from ref. 6)" for example. We require a letter of permission from the copyright holder (usually the publisher, not the author) of the original graph.

Tables

Please avoid submitting tables in digital format as our tables follow a specific style guideline for consistency. Typeset your tables in a word processing document and amend the file to your text document.

Supplementary Web Information

In some cases we reserve the right to move additional details describing experimental methods or providing supplementary data that is relevant to the conclusions of a paper to the Nature Immunology Web site. Such supplementary information often cannot be included in the print version due to space constraints. However, this material is peer-reviewed when the manuscript is under consideration and is posted on the Web site at the time of publication. Supplementary information cannot be altered by the author after the paper has been accepted for publication.

Authors should note that Supplementary Information is not copy edited by Nature Immunology, so they should ensure that it is clearly and succinctly presented, and that the style of terms conforms with the rest of the paper. The following guidelines (also available as a separate printable PDF) detail the creation, citation and submission of supplementary information.

Preparing Supplementary Information for Nature Immunology

Where there is supplementary information to be included exclusively in the online version of a paper published in Nature Immunology, please follow these guidelines. Publication will be delayed if these guidelines are not followed.

How to cite supplementary information within the text of your article
Refer to each piece of supplementary information at least once within the text of the main article (the article that is published in the print issue of the journal), using the following guidelines:

  • Designate each item as either Supplementary Table, Figure, Note, or Methods.
  • Number Supplementary Tables and Figures as, for example, "Supplementary Table 1," and provide a title for each one (for figures, please include the number and title in the caption). This numbering should be separate from that used in tables and figures appearing in the main printed article. Supplementary Note or Methods should not be numbered; titles for these are optional.
  • Refer to each piece of supplementary material at the appropriate point(s) in the main article. Be sure to include the word "Supplementary" each time one is mentioned.
  • Use the following samples as a guide (note: abbreviate "Figure" as "Fig." when in parentheses).
    "Table 1 provides a selected subset of the most active compounds. The entire list of 96 compounds can be found as Supplementary Table 1 online."
    "The biosynthetic pathway of L-ascorbic acid in animals involves intermediates of the D-glucuronic acid pathway (see Supplementary Fig. 2 online). Figure 2 shows..."

How to submit files electronically
Our normal limit is 8 items. These should be submitted as web-ready files through Nature Immunology's online manuscript submission system (http://www.nature.com/ni/esubmission/). Please check the final version carefully, as supplementary information may not be modified by authors after acceptance. Supplementary information is not copy edited by the journal, so please ensure that it is clearly and succinctly presented, and that the style of terms conforms with the rest of the paper. Manuscripts will not be accepted for publication by Nature Immunology until supplementary information is received.

Acceptable file formats
Submit separate electronic files (each including a brief title and legend) in any of these formats:

.txt Plain ASCII text
.gif GIF image
.htm HTML document
.doc MS Word document
.jpg JPEG image
.swf Flash movie
.xls MS Excel spreadsheet
.pdf Adobe Acrobat file
.mov QuickTime movie
.ppt MS Power Point slide
.wav Audio file

File sizes should be as small as possible, with a maximum size of 1 MB, so that they can be downloaded quickly. PDF is our preferred format for supplementary material. All panels of a figure or table (e.g., Fig. 1a, b and c) should be combined into one file; please do not send separate files." Image files should be just large enough to view when the screen resolution is set to 640 x 480 pixels. Audio and video files should use a frame size no larger than 320 x 240 pixels. Remember to include a brief title and legend (preferably incorporated into the image file to appear near the image) as part of every electronic figure submitted, and a title as part of every table.

Further queries about submission and preparation of supplementary information should be directed to the editor handling the manuscript.

Digital Figures Guide

We always prefer digital to printed artwork. If you do supply us with digital artwork in a suitable format it will help ensure high quality reproduction of your figures in the printed journal and on the website.

Electronic artwork

  • Artwork should be created using Photoshop or Illustrator software. Canvas, PowerPoint and MacDraw pro files are not acceptable. The final versions should be saved as TIFF, EPS or Postscript files.
  • All figures should be saved as high resolution and at your desired final reproduction size. The files should be named with the corresponding author's name, figure number and file format (e.g. smith3a.tiff; do not use slashes (/,\)) and then uploaded to the Nature Immunology FTP site. The software, Fetch, that allows you to do this can be downloaded easily from the Internet and is available free of charge. If you would like more instructions on how to do this, email Immunology@natureny.com.
  • Alternatively figures may be supplied to us on a zip disk or CD-Rom. Mac and PC formats are both acceptable.
  • For line artwork the resolution should be 1,200 dpi, halftones (or grayscales) should be 600 dpi and color artwork should be saved as 300 dpi. Anything less than these standards will not reproduce well and will delay publication until we receive usable files or high quality originals to scan. We cannot be held responsible for assuming the cost of corrected reprints should poor quality images need to be used.
  • Color figures should be converted to CMYK from RGB to maintain the integrity of your color distinctions.
  • Halftones (usually photographs of gels) should saved as grayscales NOT as CMYK or RGB. Converting CMYK/RGB formatted halftones into grayscales usually results in loss of tonal integrity, so we have to treat it as a color figure, which will incur a color fee.
  • In the event that we are unable to use your digital artwork, we will arrange for the originals to be scanned. In view of this, in addition to the electronic copy you submit, please ensure you enclose original artwork or a first-generation glossy print of high quality so that we can achieve the best results possible.

Color Charges

To help defray the cost of color printing, we charge for color figures, unless otherwise agreed. For the first three pages, this charge is $500 for the first figure and $250 for each one thereafter. Otherwise, there are no submission fees or page charges. Please contact the Production Department for further information.
 

Proofreading Pages and Figures

 
We send authors their galleys as PDF files for proofreading. We are always on tight production deadlines and, to avoid unnecessary delays in publication, require that author corrections be returned within 24 hours. All text and figures need close examination, to ensure that no errors have been introduced in our final production stages. Editorial changes will have been made to ensure clarity and consistency with Nature Immunology style, and the editors may also have suggested certain areas that warrant updating or revising on the proofs. Please supply the production editor with (1) a marked copy of the proofs and (2) a detailed point-by-point list enumerating any changes.

Contact Information

 

If you have any technical questions concerning production issues, please contact our Production Department by telephone (212) 726-9352, fax: (212) 696-0652 or e-mail: c.chau@natureny.com.

The editorial staff can be reached by telephone (212) 726 9207, fax (212) 696 9752 or e-mail immunology@natureny.com.

Reprints may be ordered from our Reprint Department: telephone (212) 726-9200, fax (212) 696-9591 or (212) 679-0843 or e-mail reprints@natureny.com


Editorial Board

 

General editorial inquiries and correspondence should be directed to:


The Editor
Nature Immunology
345 Park Avenue South
New York NY 10010-1707

tel: (212) 726-9207 fax: (212) 696-9752
email: immunology@natureny.com

Copyright © 2014 武汉大学图书馆 版权所有